Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Very short patch repair endonuclease (Vsr) is a specialized bacterial enzyme that plays a pivotal role in the Very Short Patch (VSP) repair pathway. Its primary biological function is to correct T:G mismatches that arise from the spontaneous hydrolytic deamination of 5-methylcytosine to thymine, a common occurrence at DNA cytosine methyltransferase (Dcm) recognition sites, typically 5'-CCWGG-3' (PMID: 22912483, 10612397). Vsr recognizes these mismatches and introduces a strand-specific nick 5' to the mismatched thymine, which then allows DNA polymerase I and DNA ligase to restore the original C:G base pair (PMID: 11557809). This mechanism is essential for maintaining genomic stability and preventing C-to-T transition mutations in various bacteria, including Escherichia coli and Neisseria gonorrhoeae (PMID: 30161155). While Vsr is not currently a target for clinical therapeutics, it is a subject of significant interest in the study of bacterial mutation rates, evolution, and the development of antibiotic resistance (PMID: 25877151). Structurally, Vsr belongs to a unique class of endonucleases that share a fold with type II restriction enzymes but utilize a distinct catalytic mechanism involving a critical histidine residue and metal-ion coordination (PMID: 10612397).
The enzyme recognizes T:G mismatches within specific DNA sequences (typically 5'-CCWGG-3') and catalyzes a strand-specific nick 5' to the mismatched thymine to initiate repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Very short patch repair endonuclease (Vsr).